Despite the observational nature of this pharmacovigilance study and the inherent limitations of the FAERS database, our preliminary findings in this work could provide a better basis for understanding the potential psychiatric AEs that may occur with GLP-1 RA treatment, assisting clinicians to focus on these AEs and provide early intervention for optimal risk management
Use Case: Ideal for people seeking improved physical performance, anti-aging benefits, and overall well-being
Last updated: BPC-157 has shown positive effects on gastric motility in animal models, but no human clinical trial has tested it specifically for gastroparesis
RajaKhan N, Agito K, Shah J, et al
10.1016/j.biomaterials.2020.120278 82 ZhangM.GuoX.WangM.LiuK
Access to Leading Treatments: We proudly offer Semaglutide and Tirzepatide injectionstwo of the most effective GLP-1 therapies available today